CRISPR draws mixed views from analysts after data for allogeneic CAR-T therapy
October 13 2021 - 8:15AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Allogene Therapeutics (NASDAQ:ALLO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Allogene Therapeutics (NASDAQ:ALLO)
Historical Stock Chart
From Apr 2023 to Apr 2024